Pfizer's experimental coronavirus vaccine succeeded in the final stage of clinical trials, the drugmaker said Monday, a milestone in society's fight against the pandemic.
The study found people who got Pfizer's shot were less likely to develop COVID-19, the disease caused by the novel coronavirus. The drugmaker said the shot was found to be more than 90% effective in preventing COVID-19.
The trial is still ongoing, and the interim results have not been published in a peer-reviewed medical journal.
Democrats made the 2020 election all about healthcare, and are prepared to expand the Affordable Care Act.
The Senate races aren't over yet, but Republicans' apparent hold on the upper chamber would create an insurmountable hurdle to Democrats' most ambitious healthcare goals.
The chances of the first new Alzheimer's drug in nearly 20 years reaching the market received a major blow on Friday.
An independent group of experts convened by the US Food and Drug Administration predominantly disputed the idea that there's enough evidence to show Biogen's drug aducanumab is effective or approvable.
The panel's negative recommendations on aducanumab stand in stark contrast to the FDA's own position.
